Itschak Lamensdorf
Overview
Explore the profile of Itschak Lamensdorf including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
74
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vit J, Fuchs D, Angel A, Levy A, Lamensdorf I, Black K, et al.
Bio Protoc
. 2021 Dec;
11(22):e4234.
PMID: 34909455
Visual impairments, notably loss of contrast sensitivity and color vision, were documented in Alzheimer's disease (AD) patients yet are critically understudied. This protocol describes a novel visual-stimuli four-arm maze (ViS4M;...
2.
Vit J, Fuchs D, Angel A, Levy A, Lamensdorf I, Black K, et al.
Sci Rep
. 2021 Jan;
11(1):1255.
PMID: 33441984
We introduce a novel visual-stimuli four-arm maze (ViS4M) equipped with spectrally- and intensity-controlled LED emitters and dynamic grayscale objects that relies on innate exploratory behavior to assess color and contrast...
3.
Jeanne A, Rattenbach R, Lamensdorf I, Martiny L, Martin C, Dedieu S
Pediatr Res
. 2019 Feb;
85(5):734.
PMID: 30765869
The authors "Revital Rattenbach", "ltschak Lamensdorf", and "Celine Martin" were not included in the author list of this published article however should be considered to be authors since they contributed...
4.
Porat Y, Assa-Kunik E, Belkin M, Krakovsky M, Lamensdorf I, Duvdevani R, et al.
Diabetes Metab Res Rev
. 2014 Mar;
30(7):623-34.
PMID: 24638886
Background: Vascular diseases are a major cause of morbidity and mortality, particularly in diabetic patients. Stem/progenitor cell treatments with bone marrow-derived cells show safety and promising outcomes, albeit not without...
5.
Abu Fanne R, Nassar T, Yarovoi S, Rayan A, Lamensdorf I, Karakoveski M, et al.
Neuropharmacology
. 2010 Jan;
58(7):972-80.
PMID: 20060006
Tissue type plasminogen activator (tPA) can induce neuronal apoptosis, disrupt the blood-brain barrier (BBB), and promote dilation of the cerebral vasculature. The timing, sequence and contributions of these and other...
6.
Ramot Y, Manno R, Okazaki Y, Krakovsky M, Lamensdorf I, Meiron M, et al.
Toxicol Pathol
. 2009 May;
37(5):667-71.
PMID: 19474416
We examined whether high incidence rates (18%-56%) of inflammation in the root of the aorta detected in a Balb/c mouse model for hind limb ischemia were related to the surgical...
7.
Yarnitsky D, Gross Y, Lorian A, Shalev A, Lamensdorf I, Bornstein R, et al.
J Neurosurg
. 2004 Aug;
101(2):303-9.
PMID: 15309923
Object: Drug delivery across the blood-brain barrier remains a significant challenge. Based on earlier findings, the authors hypothesized that parasympathetic innervation of the brain vasculature could be used to augment...